GHK-Cu Phase 2 Trial: What the 2026 CuHeal Study Is Testing
The 2026 CuHeal Phase 2 trial is testing GHK-Cu gel in a paired wound model. Review its design, endpoints, prior evidence context, and key limits.
30
Aug
27
Aug
DSIP Peptide Research: Sleep Evidence and Unresolved Biology
Explore DSIP peptide research, from its 1977 rabbit discovery to small human sleep studies, ACTH findings, conflicting results, and unresolved biology.
23
Aug
Thymosin Alpha-1 Research: T Cells and Cancer Immunity
Review 2026 Thymosin Alpha-1 research on dendritic-cell TLR7 signaling, CD8 T-cell activation, exhaustion markers, HCC models, and evidence limits.
20
Aug
AOD9604 Research: HGH Fragment Biology, Trials, and Evidence
Review AOD9604 research on HGH fragment structure, fat-metabolism models, human trial history, regulatory context, and major evidence limits.
16
Aug
Selank Research: Mechanisms, Evidence, and Study Limitations
Explore Selank research on GABAergic signalling, stress models, human pilot studies, its differences from Semax, and important evidence limitations.
13
Aug
Kisspeptin Research: GnRH Signaling, Reproductive Biology, and Evidence
Explore kisspeptin research, KISS1R and GnRH signaling, human endocrine studies, evidence limits, key definitions, and researcher FAQs.
09
Aug
Semax Peptide Research: What Studies Show About This Neuropeptide
Semax is a synthetic neuropeptide that has attracted research attention for its effects on cognitive function, neuroprotection, and bra...
02
Aug
BPC-157 Human Tissue Research Brief
BPC-157 human tissue research, evidence-ranking guidance, and a clinical comparison with RAD-140 research.